Different Types of Luciferase Reporters Show Distinct Susceptibility to T3-Evoked Downregulation

Kollár, A [Kollár, Anna (Neuroendokrinológia), author]; Kvárta-Papp, Z [Papp, Zsuzsanna (Molekuláris bioló...), author]; Egri, P [Egri, Péter (Endokrinológia), author] Laboratory of Molecular Cell Metabolism; Gereben, B ✉ [Gereben, Balázs (Pajzsmirigy endok...), author] Laboratory of Molecular Cell Metabolism

English Article (Journal Article) Scientific
Published: THYROID 1050-7256 1557-9077 26 (1) pp. 179-182 2016
  • SJR Scopus - Medicine (miscellaneous): D1
Identifiers
Subjects:
  • Biological sciences
  • Other medical sciences
  • Clinical medicine
BACKGROUND: The firefly luciferase reporter protein is a crucial tool for studies targeting a broad range of biological questions. Importantly, luciferase assays are also widely used to explore mechanisms underlying thyroid hormone dependent regulation of gene expression. However, it was demonstrated that the firefly luciferase reporter is subject to triiodothyronine (T3)-evoked, promoter independent downregulation that is mediated by the thyroid hormone receptor. Since this effect can interfere with readout accuracy, the study aimed to find luciferase reporters that are not susceptible to this phenomenon. METHODS: Luciferase reporter constructs were generated under the control of a minimal thymidine kinase (TK) promoter and transiently transfected into JEG-3 cells to test their activity upon T3 treatment. RESULTS: Activity of the TK-(dCpG)Luc encoding a synthetic (dCpG)Luciferase and TK-NanoLuc expressing the NanoLuc reporter was not significantly changed by T3 treatment while the firefly luciferase control was suppressed by approximately 2.6-fold. T3 also downregulated the activity of Renilla luciferase by approximately 30%. CONCLUSIONS: Novel types of luciferase reporters, especially the synthetic (dCpG)Luciferase, can be more accurate to study T3-regulated gene expression than the classical firefly luciferase reporter. Renilla luciferase, a popular transfection control of dual luciferase assays, should be used with caution in conditions with T3 treatment.
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2026-10-08 12:39